0
0
5/18/21 at 7:56pm
Organization
MarketWatch
Author
Rupert Steiner
33 words
0
Comments
Trial participants have 10 times more antibodies in their systems than patients recovering from COVID-19
You are the first to view
https://www.marketwatch.com/story/a-plant-based-vaccine-from-a-glaxosmithkline-alliance-with-medicago-shows-strong-antibody-response-11621349865
Create an account
or login to join the discussion